Building C, Suite 270, 2nd Floor 400 Interpace Parkway Parsippany , NJ 07054 United StatesFEI 3002806419Issued Mar 3, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3002806419.
Violations2
Issue DateMar 3, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Simtra BioPharma Solutions
Location
Building C, Suite 270, 2nd Floor 400 Interpace Parkway Parsippany , NJ 07054 United States
FEI Number
3002806419
Country
United States
Issue Date
March 03, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Simtra BioPharma Solutions FDA Warning Letter, March 3, 2026
Talk to a Specialist